Rewiring Food Allergy Management: From Allergen Detection to Immune Engineering Therapies. (PubMed, Immunol Invest) - Oct 16, 2026 - "Biologics (e.g. omalizumab, dupilumab) have broadened treatment options, while next-generation platforms - virus-like particle vaccines and microbiome-augmented protocols - are unlocking novel paths toward sustained unresponsiveness. This review outlines an emerging framework of immune engineering poised to redefine the future of allergy care."
Journal • Review • Allergy • Food Hypersensitivity • Immunology
|
|
Jiaqi Meng; Leyan Zhao; Pengcheng Wei; Qinglin Wei
|